PURPOSE: The purpose of this study was to evaluate the influence of 3D brachytherapy planning time on the real dose distribution. MATERIAL AND METHODS: 10 patients with cervical cancer were evaluated using 2 computed tomography (CT) scans brachytherapy. The first scan was performed after the insertion of UVAG applicators, and the second was done after creating the treatment plan, just before the irradiation of first and third fraction. Both plans were compared in terms of changes of volumes and differences in the dose for high-risk organs using GEC-ESTRO Working Group parameters. RESULTS: The median planning time was 54 minutes (36-64 minutes). The absolute median change of volume for bladder, rectum, and sigmoid was 32.1 cm3 (1.6-108.6 cm3), 5.6 cm3 (0.4-61.8 cm3), and 8.4 cm3 (0.2-74.1 cm3), respectively. This difference led to an increased dose for bladder and sigmoid for D0.1cc by 46.7 cGy and 25.7 cGy, for D1cc by 59.2 cGy and 11.8 cGy, and for D2cc by 44.7 cGy and 10 cGy, respectively, per each fraction. Measured volume change in case of rectum led to a decreased dose per each fraction for D0.1cc with 7.1 cGy, for D1cc with 3.5 cGy, and for D2cc with 4.8 cGy. We observed that statistically significant dependency between the planning time and the dose was proved for rectum. The longer time for planning, the higher dose for rectum. The correlation coefficient for D0.1cc was 0.6715 (p = 0.0061), for D1cc was 0.6404 (p = 0.011), and for D2cc was 0.5891 (p = 0.0197). CONCLUSIONS: Extended treatment planning time for brachytherapy due to the changes in topography of small pelvis can lead to different dose in high-risk organs than previously planned. It seems that the most significant changes are related to rectum.

1st Faculty of Medicine Charles University Prague Czech Republic

Comprehensive Cancer Centre Multiscan Pardubice Czech Republic

Comprehensive Cancer Centre Novy Jicin Czech Republic

Department of Oncology Palacký University Medical School and Teaching Hospital Olomouc Czech Republic

Faculty of Medicine Palacký University Olomouc Olomouc Czech Republic

See more in PubMed

Han K, Milosevic M, Fyles A et al. . Trends in the utilization of brachytherapy in cervical cancer in the United States. Int J Radiat Oncol Biol Phys 2013; 87: 111-119. PubMed

Fellner C, Pötter R, Knocke T et al. . Comparison of radiography-and computed tomography-based treatment planning in cervix cancer in brachytherapy with specificn attention to some quality assurance aspects. Radiother Oncol 2001; 58: 53-62. PubMed

Pötter R, Dimopoulos J, Georg P et al. . Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 2007; 83: 148-155. PubMed

Dolezel M, Odrazka K, Vanasek J et al. . MRI-based preplanning in patients with cervical cancer treated with 3D brachytherapy. Br J Radiol 2011; 84: 850-856. PubMed PMC

Dolezel M, Odrazka K, Zizka J et al. . MRI-based preplanning using CT and MRI data fusion in patients with cervical cancer treated with 3D-based brachytherapy: feasibility and accuracy study. Int J Radiat Oncol Biol Phys 2012; 84: 146-152. PubMed

Gerbaulet A, Potter R, Mazeron JJ et al. (eds.). The GEC ESTRO Handbook of Brachytherapy 2003.

Shin K, Kim T, Cho J et al. . CT-guded intracavitary radiotherapy for cervical cancer: Comparison of conventional Point A plan with clinical target volume-based 3D plan using dose-volume parameters. Int J Radiat Oncol Biol Phys 2006; 64: 197-204. PubMed

van Heerden LE, Visser J, Koedooder K et al. . Role of deformable image registration for delivered dose accumulation of adaptive external beam radiation therapy and brachytherapy in cervical cancer. J Contemp Brachytherapy 2018; 10: 542-550. PubMed PMC

Murakami N, Shima S, Kashihara T et al. . Hyaluronic gel injection into the vesicovaginal septum for high-dose-rate brachytherapy of uterine cervical cancer: an effective approach for bladder dose reduction. J Contemp Brachytherapy 2019; 11: 1-7. PubMed PMC

Mahantshetty U, Gudi S, Singh R et al. . Indian Brachytherapy Society Guidelines for radiotherapeutic management of cervical cancer with special emphasis on high-dose-rate brachytherapy. J Contemp Brachytherapy 2019; 11: 293-306. PubMed PMC

Pötter R, Georg P, Dimopoulos JC et al. . Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol 2011; 100: 116-123. PubMed PMC

Haie-Meder C, Potter R, Van Limbergen E et al. . Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group(I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005; 74: 235-245. PubMed

Pötter R, Haie-Meder C, Van Limbergen E et al. . Recommendations from gynaecological (GYN) GEC ESTRO working group(II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiationphysics, radiobiology. Radiother Oncol 2006; 78: 67-77. PubMed

Hellebust TP, Kirisits C, Berger D et al. . Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy. Radiother Oncol 2010; 96: 153-160. PubMed

Dimopoulos JC, Petrow P, Tanderup K et al. . Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol 2012; 103: 113-122. PubMed PMC

Lindegaard JC, Fokdal LU, Nielsen SK et al. . MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective. Acta Oncol 2013; 52: 1510-1519. PubMed

Sturdza A, Pötter R, Fokdal LU et al. . Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. Radiother Oncol 2016; 120: 428-433. PubMed

Tanderup K, Fokdal LU, Sturdza A et al. . Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer. Radiother Oncol 2016; 120: 441-446. PubMed

Kirchheiner K, Pötter R, Tanderup K et al. . Health-related quality of life in locally advanced cervical cancer patients after definitive chemoradiation therapy including image guided adaptive brachytherapy: an analysis from the EMBRACE study. Int J Radiat Oncol Biol Phys 2016; 94: 1088-1098. PubMed

Mazeron R, Fokdal LU, Kirchheiner K et al. . Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study. Radiother Oncol 2016; 120: 412-419. PubMed

Siavashpour Z, Aghamiri MR, Jaberi R et al. . Optimum organ volume ranges for organs at risk dose in cervical cancer intracavitary brachytherapy. J Contemp Brachytherapy 2016; 8: 135-142. PubMed PMC

Schindel J, Zhang W, Bhatia SK et al. . Dosimetric impacts of applicator displacements and applicator reconstruction-uncertainties on 3D image-guided brachytherapy for cervical cancer. J Contemp Brachytherapy 2013; 5: 250-257. PubMed PMC